New Zealand founders can combine local angel networks, first-cheque venture capital and specialist science investors. These 12 providers are compared by mandate and capital type, with trans-Tasman and wider strategies clearly labelled.
Use this list to build a focused research queue. Start with your company’s stage, the evidence you have and the milestone the round should finance. Then choose a small set of relevant providers, confirm the current mandate and plan an appropriate first conversation.
New Zealand capital at a glance
This is a selective, unranked directory of 12 provider families. A venture fund, angel network, co-investor and growth or strategic investor can serve different company needs. The scope column records geographic, institutional or investment-stage context, not a claim that every organization is headquartered locally.
| Provider | Capital route | Investment scope |
|---|---|---|
| Movac | Technology VC | New Zealand |
| Icehouse Ventures | Multi-stage VC | Kiwi-founded companies |
| Blackbird | VC | Australia and New Zealand ecosystem |
| GD1 | Early-stage VC | New Zealand founders |
| Outset Ventures | Deep-tech investor and laboratory ecosystem | New Zealand |
| Pacific Channel | Deep-tech VC | Asia-Pacific; health, food and environment |
| Punakaiki Fund | Evergreen VC | New Zealand technology |
| WNT Ventures | Early deep-tech investor | New Zealand |
| Matū | Science and deep-tech VC | Aotearoa New Zealand |
| Angel HQ | Angel club | Wellington; New Zealand companies |
| Flying Kiwi Angels | Angel network | New Zealand startups |
| Enterprise Angels | Angel investment network | Early-stage New Zealand companies |
Plan the first market and the first international proof separately
- Distinguish early company validation from a growth round or an opportunity fund.
- For scientific businesses, connect laboratory evidence with customer deployment and development costs.
- Explain the New Zealand or Kiwi-founder connection required by the specific investor.
Illustrative example: a New Zealand industrial-science team has repeatable laboratory results and a prospective overseas customer. It prioritizes local deep-tech and seed routes, then records what evidence would make international scaling credible. A growth opportunity fund is researched as a later relationship, not presented as the first financing option.
Avoid this shortcut: An investor-facing fund offer is not a founder application. An evergreen structure also does not mean every company or round qualifies.
12 providers to research
1. Movac
Technology VC. New Zealand.
Movac backs New Zealand technology founders and provides resources for companies seeking seed or growth capital. Movac official information.
Prepare before outreach: Check the current fund and team for the round’s stage, rather than assuming the whole platform operates as one seed vehicle.
2. Icehouse Ventures
Multi-stage VC. Kiwi-founded companies.
Icehouse invests in Kiwi founders and describes support from early company building through later growth. Icehouse Ventures official information.
Prepare before outreach: Identify the appropriate fund and financing milestone. Founder origin and operating geography should be discussed directly.
3. Blackbird
VC. Australia and New Zealand ecosystem.
Blackbird invests from the earliest company stages and publishes New Zealand founder and community activity. Blackbird official information.
Prepare before outreach: Explain both the immediate proof point and the larger company ambition, without treating community participation as an investment commitment.
4. GD1
Early-stage VC. New Zealand founders.
GD1 writes first cheques at pre-seed, leads Series A rounds and follows through later stages, with science and engineering themes in its thesis. GD1 official information.
Prepare before outreach: Clarify whether you need first institutional capital or a scale round and what evidence supports that transition.
5. Outset Ventures
Deep-tech investor and laboratory ecosystem. New Zealand.
Outset combines a deep-tech venture fund with laboratories and a founder community, and separately describes an opportunity fund for scaling companies. Outset Ventures official information.
Prepare before outreach: Separate the facilities need, early investment route and later opportunity-fund fit.
6. Pacific Channel
Deep-tech VC. Asia-Pacific; health, food and environment.
Pacific Channel invests from pre-seed through Series A in scientific and technical innovation across health, food and the environment. Pacific Channel official information.
Prepare before outreach: Prepare scientific proof and a commercial translation plan. A good research result alone does not answer the customer question.
7. Punakaiki Fund
Evergreen VC. New Zealand technology.
Punakaiki uses an evergreen investment structure to back high-growth New Zealand technology businesses. Punakaiki Fund official information.
Prepare before outreach: Use the company-facing capital route, not a dated investor subscription offer, and confirm current financing criteria.
8. WNT Ventures
Early deep-tech investor. New Zealand.
WNT engages with deep-tech entrepreneurs at an early stage and emphasizes local company building for global markets. WNT Ventures official information.
Prepare before outreach: Show the technical risk being retired and how the first market validates a larger opportunity.
9. Matū
Science and deep-tech VC. Aotearoa New Zealand.
Matū operates venture funds with a hands-on approach to scientific and deep-tech companies. Matū official information.
Prepare before outreach: Explain the IP-rich company opportunity and the scientific, governance and operating support needed.
10. Angel HQ
Angel club. Wellington; New Zealand companies.
Angel HQ is a Wellington-based investor community that backs New Zealand businesses. Angel HQ official information.
Prepare before outreach: Prepare the founder application and identify relevant member expertise without assuming the club is one institutional fund.
11. Flying Kiwi Angels
Angel network. New Zealand startups.
Flying Kiwi Angels publishes its startup portfolio and current financing activity through an angel-investment community. Flying Kiwi Angels official information.
Prepare before outreach: Confirm the founder route and current process. A company marked as raising on a portfolio page is not a commitment to a new applicant.
12. Enterprise Angels
Angel investment network. Early-stage New Zealand companies.
Enterprise Angels connects early-stage companies with business angels and facilitates investor participation. Enterprise Angels official information.
Prepare before outreach: Check the company screening process and distinguish primary fundraising from secondary share offers on the platform.
Turn the directory into your next five research actions
Choose five providers with a plausible mandate match, not five familiar logos. For each one, keep a source and one unresolved fit question beside the next action. Leave unknown information blank until you can verify it.
A compact investor-fit worksheet
Copy one record per provider. Replace the bracketed fields with company-specific evidence.
New Zealand investor research
Provider: [name and specific fund]
Official source + checked date: [URL, date]
Why our stage and technology fit: [evidence]
Geographic or institutional connection: [evidence]
Milestone this round finances: [specific result]
Open fit question: [one question]
Introduction or founder route: [verified route]
Owner + next action + date: [person, action, date]
Decision: [research next / ask a question / hold]Move a provider forward when the current mandate and your company evidence match. Ask a question when one material criterion is unclear. Hold when the fund is at the wrong stage, serves a different company geography or expects evidence you do not yet have. Do not treat a contact record as investor interest.
Give Aurora, Claude or Codex a focused research mission
Use this prompt with Aurora in Finta, Claude or Codex. Add only material you are authorized to share. Review the result before adding records or contacting anyone.
Be my New Zealand investor-research teammate.
Company: [one sentence, stage and location]
Technology or business model: [specific scope]
Evidence we have: [authorized facts only]
Next financing milestone: [result to fund]
Candidates: [paste five provider names from this guide]
Check each provider's current official sources.
Return: fit evidence, source URL/date, one open question, next action.
Separate local presence, investment reach and eligibility.
Mark missing facts unknown; do not invent cheque sizes or contacts.
Check portfolio conflicts before suggesting sensitive material.
Draft a research queue only. Do not contact or submit to anyone.Keep the next step moving
A useful shortlist connects investor fit to a relationship owner and a specific next action. Use Finta’s investor-prospecting workflow to organize the research. Keep the official source, contact context and follow-up together in your fundraising pipeline.
Before asking for an introduction, review portfolio conflicts and prepare a relevant message. The warm-introduction guide explains how to make a clear, permission-aware request. A possible path is not a completed introduction or a financing commitment.
A common founder question
Should a New Zealand company include Australian investors?
Yes, when the actual mandate covers Kiwi founders or New Zealand companies. Label that wider reach and confirm the investment team’s current fit.
How this list was researched
Research reviewed on October 28, 2026 using the linked official investment, portfolio and program pages. We count related firms and vehicles as one provider family where noted. Order is not a performance ranking. Public mandate evidence does not establish uncommitted capital, an open application window or an offer to invest; confirm the current process directly. The cover is an illustrative ecosystem, not a literal map or an investor-network diagram.
Authored by Finta Editorial Team. Source review was AI-assisted; hypothetical examples are labelled illustrative and are not customer results.
Informational guidance
This content is for general informational and educational purposes, not personalized investment, financial, legal or tax advice. Finta is not a law firm. Consult your attorney or accountant about financing documents, eligibility, intellectual property, tax treatment and your company’s circumstances.